VKH
VKTX icon

Virtu KCG Holdings’s Viking Therapeutics VKTX Stock Holding History

Virtu KCG Holdings’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$124K Buy
+114,507
New +$146K ﹤0.01% 2358
2016
Q4 		– Sell
-23,578
Closed -$33K – 3823
2016
Q3 		$33K Buy
+23,578
New +$31.2K ﹤0.01% 2857
2015
Q3 		– Sell
-11,403
Closed -$81K – 3842
2015
Q2 		$81K Buy
+11,403
New +$94.3K ﹤0.01% 2975

Other funds holding VKTX

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu KCG Holdings's VKTX Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Viking Therapeutics (VKTX) in Q2 2017: 114,507 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #2358 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in VKTX as recently as Q3 2016.

Virtu KCG Holdings first reported a position in VKTX in Q2 2015 and has held it in 3 quarters since. 12 funds tracked by Wall St. Rank hold VKTX as of Q2 2017.

  • Virtu KCG Holdings held 114,507 shares of Viking Therapeutics worth $124K as of Q2 2017.
  • Viking Therapeutics was a new Virtu KCG Holdings position in Q2 2017.
  • Viking Therapeutics made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2358 holding.
  • Virtu KCG Holdings first reported a position in Viking Therapeutics in Q2 2015 and has held it in 3 quarters since.
  • 12 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.